|
USA-641112-Insurance ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
See Important Safety Information, including Boxed Warning How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help
- Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD) Includes Austedo side effects, dosage, uses, interactions, and more
- Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) extended . . .
See Prescribing Information, including Boxed Warning Find information for healthcare professionals about once-daily AUSTEDO XR
- Tardive Dyskinesia: Symptoms, Causes, Treatment, and More
Tardive dyskinesia is a side effect caused by neuroleptic drugs Learn more about why this happens and a list of medications commonly linked with tardive dyskinesia
- Austedo (deutetrabenazine): Uses, Side Effects, Interactions . . . - WebMD
Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Medication-Induced Tardive Dyskinesia: A Review and Update
Tardive dyskinesia (TD) is a movement disorder that causes involuntary, repetitive body movements and is commonly seen in patients who are on long-term treatment with antipsychotic medications However, several other classes of medications with
- Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity
New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia
- Austedo (deutetrabenazine): Uses, Side Effects, Dosage More - GoodRx
Learn about Austedo (deutetrabenazine) usage and dosing Read the latest news and reviews about the drug as well as potential side effects and popular alternatives
- deutetrabenazine monograph - Texas Health and Human Services
Lactation Risk Summary: There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for deutetrabenazine (Austedo) and any potential adverse effects on the breastfed
- Recognition and Management of Antipsychotic-induced Movement Disorders
Recognition and Management of Antipsychotic-induced Movement Disorders Antipsychotic-induced movement disorders commonly seen in clinical practice include parkinsonism, akathisia, tardive dyskinesia and acute dystonia The prevalence of antipsychotic-induced movement disorders is about 37% (95% CI, 18-55%), where 20% of people on an antipsychotic medication experience parkinsonism, 11%
|
|